Continuum Advisory’s Edwards Lifesciences EW Stock Holding History

Continuum Advisory's EW Position: Q2 2026 in Review

Continuum Advisory opened a new position in Edwards Lifesciences (EW) in Q2 2026: 581 shares worth $52.6K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in EW as recently as Q1 2025.

Continuum Advisory first reported a position in EW in Q2 2021 and has held it in 16 quarters since. The position peaked at $911K in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

• Continuum Advisory held 581 shares of Edwards Lifesciences worth $52.6K as of Q2 2026.
• Edwards Lifesciences was a new Continuum Advisory position in Q2 2026.
• Edwards Lifesciences made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #787 holding.
• Continuum Advisory first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 16 quarters since.
• Continuum Advisory's Edwards Lifesciences position peaked at $911K in Q4 2021.
• 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.